Lilly launches Foundayo oral GLP-1 weight loss pill in US market

Go back to Lilly launches Foundayo oral GLP-1 weight loss pill in US market
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1103.48 +1.40 (0.13%)
Previous Close $1102.08    52 Week High $88.16 
Open $1117.00    52 Week Low $67.88 
Day High $1122.02    P/E 255.44 
Day Low $1079.22    EPS $4.32 
Volume 1,182,143